Related Experiment Video
Updated: Sep 11, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Intrinsic disorder in CYP1B1 and its implications in primary congenital glaucoma pathogenesis
Meghan Sharma1, David Taylor Gonzalez2, Michael Antonietti3
1John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
Cytochrome P450 1B1 (CYP1B1) intrinsically disordered regions may protect against mutations causing primary congenital glaucoma (PCG). This suggests a new therapeutic target for this childhood eye disorder.
Area of Science:
- Genetics and Molecular Biology
- Ophthalmology
- Biochemistry
Background:
- Primary congenital glaucoma (PCG) is a severe pediatric eye disorder linked to Cytochrome P450 1B1 (CYP1B1) mutations.
- Intrinsically disordered proteins/regions (IDPs/IDPRs) lack stable structures and influence disease pathology through altered protein interactions and function.
Purpose of the Study:
- To investigate the role of intrinsic disorder within CYP1B1 in the molecular mechanisms of PCG.
- To analyze the structural and functional properties of CYP1B1, focusing on IDPRs and their impact on mutation pathogenicity.
Main Methods:
- Utilized a comprehensive bioinformatics approach to study CYP1B1.
- Employed tools like AlphaMissense to assess the functional impact of missense mutations.
- Performed structural analysis to identify intrinsically disordered regions in CYP1B1.
Main Results:
- CYP1B1 possesses intrinsically disordered regions characterized by flexibility and lack of stable structure.
- A significant inverse correlation was observed between protein disorder and predicted mutation pathogenicity (R² = 0.62).
- Highly disordered regions in CYP1B1 appear to harbor mutations with reduced pathogenicity.
Conclusions:
- Identified critical intrinsically disordered regions in CYP1B1, potentially influencing PCG pathogenesis.
- The findings suggest that IDPRs may act as a buffer against deleterious mutations, explaining clinical outcome variability in PCG.
- This research provides insights into PCG's molecular basis and suggests potential therapeutic targets for this blinding condition.
More Related Videos
13:47Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Genetic Lingo
Inborn Errors of Metabolism
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...